Area of research
Genetics · Cancer Research
Research interest
Research interests include Glioma Diagnosis and Treatment, Cancer, Hypoxia, and Metabolism, ATP Synthase and ATPases Research, and Neuroblastoma Research and Treatments.
TMET-51. EGFR metabolically suppresses differentiation in H3K27M-mutant diffuse midline glioma
DMG-63. EGFR confers resistance to ONC201 in H3K27M-mutant diffuse midline glioma
DMG-38. Effective targeting of EGFR-driven diffuse midline glioma with X117195, a novel brain-penetrant EGFR-targeting tyrosine kinase inhibitor (TKI)
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations
A road map for the treatment of pediatric diffuse midline glioma
Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma
Patient Perceptions of SARS-CoV-2 Exposure Risk and Association With Continuity of Ophthalmic Care
Propagating Humanized BLT Mice for the Study of Human Immunology and Immunotherapy
Genetic engineering of hematopoietic stem cells to generate invariant natural killer T cells